{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T12:47:52Z","timestamp":1773146872442,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,1,26]],"date-time":"2009-01-26T00:00:00Z","timestamp":1232928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,1,26]],"date-time":"2009-01-26T00:00:00Z","timestamp":1232928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1038\/bmt.2008.429","type":"journal-article","created":{"date-parts":[[2009,1,26]],"date-time":"2009-01-26T12:42:26Z","timestamp":1232973746000},"page":"89-96","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Autologous transplantation for relapsed non-Hodgkin's lymphoma using intravenous busulfan and cyclophosphamide as conditioning regimen: a single center experience"],"prefix":"10.1038","volume":"44","author":[{"given":"M P","family":"Escal\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Stefanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Venkatraman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E S","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J J","family":"Byrnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H F","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,26]]},"reference":[{"key":"BFbmt2008429_CR1","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","volume":"333","author":"T Philip","year":"1995","unstructured":"Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med 1995; 333: 1540\u20131545.","journal-title":"N Engl J Med"},{"key":"BFbmt2008429_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1200\/JCO.1999.17.1.423","volume":"17","author":"MA Shipp","year":"1999","unstructured":"Shipp MA, Abeloff MD, Antman KH, Carroll G, Hagenbeek A, Loeffler M et al. International consensus conference on high-dose therapy with hematopoietic stem cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury. J Clin Oncol 1999; 17: 423\u2013429.","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"BFbmt2008429_CR3","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1093\/annonc\/9.suppl_1.S15","volume":"9","author":"N Mounier","year":"1998","unstructured":"Mounier N, Gisselbrecht C . Conditioning regimens before transplantation in patients with aggressive non-Hodgkin's lymphoma. Ann Oncol 1998; 9 (Suppl 1): S15\u2013S21.","journal-title":"Ann Oncol"},{"key":"BFbmt2008429_CR4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.5694\/j.1326-5377.1989.tb101219.x","volume":"151","author":"WP Sheridan","year":"1989","unstructured":"Sheridan WP, Boyd AW, Green MD, Russell DM, Thomas RJ, McGrath KM et al. High-dose chemotherapy with busulphan and cyclophosphamide and bone-marrow transplantation for drug-sensitive malignancies in adults: a preliminary report. Med J Aust 1989; 151: 379\u2013386.","journal-title":"Med J Aust"},{"key":"BFbmt2008429_CR5","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/sj.bmt.1700733","volume":"19","author":"M de Magalhaes-Silverman","year":"1997","unstructured":"de Magalhaes-Silverman M, Lister J, Rybka W, Wilson J, Ball E . Busulfan and cyclophosphamide (BU\/CY2) as preparative regimen for patients with lymphoma. Bone Marrow Transplant 1997; 19: 777\u2013781.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008429_CR6","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1053\/bbmt.2002.v8.pm11939604","volume":"8","author":"BS Andersson","year":"2002","unstructured":"Andersson BS, Kashyap A, Gian V, Wingard JR, Fernandez H, Cagnoni PJ et al. Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study. Biol Blood Marrow Transplant 2002; 8: 145\u2013154.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2008429_CR7","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.bbmt.2007.03.003","volume":"13","author":"JA Russell","year":"2007","unstructured":"Russell JA, Savoie ML, Balogh A, Turner AR, Larratt L, Chaudhry MA et al. Allogeneic transplantation for adult acute leukemia in first and second remission with a novel regimen incorporating daily intravenous busulfan, fludarabine, 400\u2009CGY total-body irradiation, and thymoglobulin. Biol Blood Marrow Transplant 2007; 13: 814\u2013821.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2008429_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1182\/blood-2004-02-0414","volume":"104","author":"M de Lima","year":"2004","unstructured":"de Lima M, Couriel D, Thall PF, Wang X, Madden T, Jones R et al. Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS. Blood 2004; 104: 857\u2013864.","journal-title":"Blood"},{"key":"BFbmt2008429_CR9","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1053\/bbmt.2002.v8.pm12374453","volume":"8","author":"HF Fernandez","year":"2002","unstructured":"Fernandez HF, Tran HT, Albrecht F, Lennon S, Caldera H, Goodman MS . Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice-daily or daily schedule to patients with advanced hematologic malignant disease undergoing stem cell transplantation. Biol Blood Marrow Transplant 2002; 8: 486\u2013492.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2008429_CR10","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B, Shipp MA, Fisher RI, Connors JM et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999; 17: 1244.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008429_CR11","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1200\/JCO.1989.7.9.1288","volume":"7","author":"SI Bearman","year":"1989","unstructured":"Bearman SI, Appelbaum FR, Back A, Petersen FB, Buckner CD, Sullivan KM et al. Regimen-related toxicity and early posttransplant survival in patients undergoing marrow transplantation for lymphoma. J Clin Oncol 1989; 7: 1288\u20131294.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008429_CR12","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1200\/JCO.1995.13.3.588","volume":"13","author":"W Mills","year":"1995","unstructured":"Mills W, Chopra R, McMillan A, Pearce R, Linch DC, Goldstone AH . BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin's lymphoma. J Clin Oncol 1995; 13: 588\u2013595.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008429_CR13","first-page":"549","volume":"15","author":"K van Besien","year":"1995","unstructured":"van Besien K, Tabocoff J, Rodriguez M, Andersson B, Mehra R, Przepiorka D et al. High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity. Bone Marrow Transplant 1995; 15: 549\u2013555.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008429_CR14","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1182\/blood-2005-01-0035","volume":"105","author":"S Bhatia","year":"2005","unstructured":"Bhatia S, Robison LL, Francisco L, Carter A, Liu Y, Grant M et al. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood 2005; 105: 4215\u20134222.","journal-title":"Blood"},{"key":"BFbmt2008429_CR15","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/sj.bmt.1701245","volume":"21","author":"N Kroger","year":"1998","unstructured":"Kroger N, Hoffknecht M, Hanel M, Kruger W, Zeller W, Stockschlader M et al. Busulfan, cyclophosphamide and etoposide as high-dose conditioning therapy in patients with malignant lymphoma and prior dose-limiting radiation therapy. Bone Marrow Transplant 1998; 21: 1171\u20131175.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2008429_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1007\/s00277-001-0413-8","volume":"81","author":"M Hanel","year":"2002","unstructured":"Hanel M, Kroger N, Sonnenberg S, Bornhauser M, Kruger W, Kroschinsky F et al. Busulfan, cyclophosphamide, and etoposide as high-dose conditioning regimen in patients with malignant lymphoma. Ann Hematol 2002; 81: 96\u2013102.","journal-title":"Ann Hematol"},{"key":"BFbmt2008429_CR17","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.bbmt.2006.03.016","volume":"12","author":"C Aggarwal","year":"2006","unstructured":"Aggarwal C, Gupta S, Vaughan WP, Saylors BG, Salzman DE, Katz RO et al. Improved outcomes in intermediate- and high-risk aggressive non-Hodgkin lymphoma after autologous hematopoietic stem cell transplantation substituting intravenous for oral busulfan in a busulfan, cyclophosphamide, and etoposide preparative regimen. Biol Blood Marrow Transplant 2006; 12: 770\u2013777.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2008429_CR18","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/annonc\/mdg008","volume":"14","author":"MD Caballero","year":"2003","unstructured":"Caballero MD, Perez-Simon JA, Iriondo A, Lahuerta J, Sierra J, Marin J et al. High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group. Ann Oncol 2003; 14: 140\u2013151.","journal-title":"Ann Oncol"},{"key":"BFbmt2008429_CR19","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1056\/NEJM198706113162401","volume":"316","author":"T Philip","year":"1987","unstructured":"Philip T, Armitage JO, Spitzer G, Chauvin F, Jagannath S, Cahn JY et al. High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin\u2032s lymphoma. N Engl J Med 1987; 316: 1493\u20131498.","journal-title":"N Engl J Med"},{"key":"BFbmt2008429_CR20","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1200\/JCO.1990.8.5.784","volume":"8","author":"AS Freedman","year":"1990","unstructured":"Freedman AS, Takvorian T, Anderson KC, Mauch P, Rabinowe SN, Blake K et al. Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse. J Clin Oncol 1990; 8: 784\u2013791.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008429_CR21","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1200\/JCO.1994.12.12.2535","volume":"12","author":"RM Stone","year":"1994","unstructured":"Stone RM, Neuberg D, Soiffer R, Takvorian T, Whelan M, Rabinowe SN et al. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol 1994; 12: 2535\u20132542.","journal-title":"J Clin Oncol"},{"key":"BFbmt2008429_CR22","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/sj.bmt.1703917","volume":"31","author":"T Cheng","year":"2003","unstructured":"Cheng T, Forsyth P, Chaudhry A, Morris D, Gluck S, Russell JA et al. High-dose thiotepa, busulfan, cyclophosphamide and ASCT without whole-brain radiotherapy for poor prognosis primary CNS lymphoma. Bone Marrow Transplant 2003; 31: 679\u2013685.","journal-title":"Bone Marrow Transplant"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2008429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008429","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2008429.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T11:51:01Z","timestamp":1648036261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2008429"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,26]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["BFbmt2008429"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2008.429","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,26]]},"assertion":[{"value":"28 January 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2008","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}